share_log

Why Avenue Therapeutics Shares Surged Around 106%; Here Are 87 Biggest Movers From Yesterday

Why Avenue Therapeutics Shares Surged Around 106%; Here Are 87 Biggest Movers From Yesterday

為什麼大道治療學股價飆升 106% 左右; 這是 87 從昨天起最大的動力
Benzinga Real-time News ·  2022/09/23 03:43
Gainers
贏家
Spero Therapeutics, Inc. (NASDAQ:SPRO) shares jumped 167.7% to close at $2.20 on Thursday after the company announced it has entered into an exclusive license agreement with GSK for Spero's late-stage antibiotic asset, tebipenem HBr. Spero Therapeutics will receive $66 million upfront, with potential for future milestone payments, and tiered royalties. Avenue Therapeutics, Inc. (NASDAQ:ATXI) gained 105.9% to close at $0.44 after the company received meeting minutes from the FDA regarding a meeting conducted on August 9, 2022, for IV Tramadol. The company also announced the effectiveness of its 1-for-15 reverse split on Sept. 23. Panbela Therapeutics, Inc. (NASDAQ:PBLA) gained 46.4% to close at...
Spero治療公司納斯達克(SPRO:SPRO)股價週四大漲167.7%,收於2.2美元,此前該公司宣佈已與葛蘭素史克就斯培羅的晚期抗生素資產泰比培南HBR達成獨家許可協議。Spero Treate...
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論